183
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

The successful management of acute promyelocytic leukemia during pregnancy: a case report

ORCID Icon, , &
Pages 526-529 | Received 04 Aug 2023, Accepted 12 Dec 2023, Published online: 19 Dec 2023
 

Disclosure statement

TB received research funding from Imago Biosciences (a subsidiary of Merck) and honoraries from Jazz Pharmaceuticals, Celgene, AVIR Pharma, Takeda Pharma, Bristol Myers Squibb, Riemser Pharma GmbH as well as travel funding from Incyte, Abbvie, Astellas, Alexion, and Celgene.

Ethics & consent

Consent was obtained from patient to publish case report. Written informed consent was provided from the patient.

Data availability statement

Due to the confidential nature of this case report, no data will be provided to the general public.

Additional information

Funding

TB received research support from the Marta and Owen Boris Foundation, the Ontario Institute for Cancer Research through funding provided by the Government of Ontario, the Canadian Foundation for Innovation, the Ontario Research Fund and the JHCC Foundation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.